QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $700.53 million. The enterprise value is $3.65 billion.
Important Dates
The last earnings date was Tuesday, November 3, 2026, after market close.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 68.61 million shares outstanding. The number of shares has increased by 1.00% in one year.
| Current Share Class | 68.61M |
| Shares Outstanding | 68.61M |
| Shares Change (YoY) | +1.00% |
| Shares Change (QoQ) | +0.59% |
| Owned by Insiders (%) | 1.14% |
| Owned by Institutions (%) | 107.88% |
| Float | 61.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.41 |
| PS Ratio | 0.27 |
| Forward PS | 0.28 |
| PB Ratio | 0.39 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 88.68 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.41 |
| EV / EBITDA | 7.89 |
| EV / EBIT | 811.21 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 1.74.
| Current Ratio | 1.36 |
| Quick Ratio | 0.62 |
| Debt / Equity | 1.74 |
| Debt / EBITDA | 6.17 |
| Debt / FCF | n/a |
| Interest Coverage | 0.02 |
Financial Efficiency
Return on equity (ROE) is -19.29% and return on invested capital (ROIC) is 0.10%.
| Return on Equity (ROE) | -19.29% |
| Return on Assets (ROA) | 0.05% |
| Return on Invested Capital (ROIC) | 0.10% |
| Return on Capital Employed (ROCE) | 0.10% |
| Weighted Average Cost of Capital (WACC) | 5.91% |
| Revenue Per Employee | $398,954 |
| Profits Per Employee | -$56,800 |
| Employee Count | 6,500 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.29 |
Taxes
In the past 12 months, QuidelOrtho has paid $33.20 million in taxes.
| Income Tax | 33.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.16% in the last 52 weeks. The beta is 0.80, so QuidelOrtho's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -52.16% |
| 50-Day Moving Average | 12.23 |
| 200-Day Moving Average | 15.29 |
| Relative Strength Index (RSI) | 36.66 |
| Average Volume (20 Days) | 2,398,054 |
Short Selling Information
The latest short interest is 14.46 million, so 21.08% of the outstanding shares have been sold short.
| Short Interest | 14.46M |
| Short Previous Month | 12.99M |
| Short % of Shares Out | 21.08% |
| Short % of Float | 23.64% |
| Short Ratio (days to cover) | 6.37 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $2.59 billion and -$369.20 million in losses. Loss per share was -$5.40.
| Revenue | 2.59B |
| Gross Profit | 1.15B |
| Operating Income | 4.50M |
| Pretax Income | -336.00M |
| Net Income | -369.20M |
| EBITDA | 462.60M |
| EBIT | 4.50M |
| Loss Per Share | -$5.40 |
Full Income Statement Balance Sheet
The company has $166.40 million in cash and $3.12 billion in debt, with a net cash position of -$2.95 billion or -$42.99 per share.
| Cash & Cash Equivalents | 166.40M |
| Total Debt | 3.12B |
| Net Cash | -2.95B |
| Net Cash Per Share | -$42.99 |
| Equity (Book Value) | 1.79B |
| Book Value Per Share | 26.11 |
| Working Capital | 378.90M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $7.90 million and capital expenditures -$125.00 million, giving a free cash flow of -$117.10 million.
| Operating Cash Flow | 7.90M |
| Capital Expenditures | -125.00M |
| Depreciation & Amortization | 458.10M |
| Net Borrowing | 274.60M |
| Free Cash Flow | -117.10M |
| FCF Per Share | -$1.71 |
Full Cash Flow Statement Margins
Gross margin is 44.50%, with operating and profit margins of 0.17% and -14.24%.
| Gross Margin | 44.50% |
| Operating Margin | 0.17% |
| Pretax Margin | -12.96% |
| Profit Margin | -14.24% |
| EBITDA Margin | 17.84% |
| EBIT Margin | 0.17% |
| FCF Margin | n/a |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.00% |
| Shareholder Yield | -1.00% |
| Earnings Yield | -52.92% |
| FCF Yield | -16.72% |
Analyst Forecast
The average price target for QuidelOrtho is $15.00, which is 46.92% higher than the current price. The consensus rating is "Hold".
| Price Target | $15.00 |
| Price Target Difference | 46.92% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -1.88% |
| EPS Growth Forecast (3Y) | -5.78% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 0.44 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.44 |
| Piotroski F-Score | 5 |